Trials / Completed
CompletedNCT01612767
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 329 (actual)
- Sponsor
- Biotronik, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the safety and efficacy of the investigational BIOTRONIK PRO-Kinetic Energy stent in subjects with atherosclerotic disease of native coronary arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PRO-Kinetic Energy Stent | Coronary artery stent implant |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-09-01
- Completion
- 2017-11-01
- First posted
- 2012-06-06
- Last updated
- 2018-09-28
- Results posted
- 2017-05-30
Locations
35 sites across 5 countries: United States, Colombia, Germany, Latvia, Netherlands
Source: ClinicalTrials.gov record NCT01612767. Inclusion in this directory is not an endorsement.